Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel

By afschroeder • August 21, 2025

Singal AG, Quirk L, Boike J, Chernyak V, Feng Z, Giamarqo G, Kanwal F, Ioannou GN, Manes S, Marrero JA, Mehta N, Pillai A, Shaheen NJ, Shaukat A, Sirlin CB, Verna E, Wani S, Wilson Woods A, Yang JD, Parikh ND. Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel. Hepatology. 2025 Sep 1;82(3):794-809. doi: 10.1097/HEP.0000000000001203. Epub 2024 Dec 18. PMID: 40833999.

Tags: Biomarker, Cedars Sinai DoM, Cirrhosis, Digestive Diseases, liver cancer, Publications, screening, ultrasound

Pulmonary Primary Oxysterol and Bile Acid Synthesis as a Predictor of Outcomes in Pulmonary Arterial Hypertension

Alotaibi M, Harvey LD, Nichols WC, Hemnes A, Sun W, Begzati A, Long T, Havulinna AS, Niiranen TJ, Desai AA, Cheng S, Jain M, Chan[...]

Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE

Rugo HS, Tolaney SM, Chan N, Borges G, Yerushalmi R, Sharifi MN, McHayleh W, Beck T, Vidula N, Hamilton E, Rinn KJ, O'Shaughnessy J, Curigliano[...]

Insights on supplement use during cancer care from online Reddit conversations

Waissengrin B, O'Connor K, Shirazipour CH, Ivan FA, Reckamp KL, Gonzalez-Hernandez G, Figueiredo JC. Insights on supplement use during cancer care from online Reddit conversations.[...]